Table of Contents

company-logo

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. Its lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada.

NervGen Pharma Dividend Announcement

• NervGen Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on NervGen Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

NervGen Pharma Dividend History

NervGen Pharma Dividend Yield

NervGen Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NervGen Pharma stock? Use our calculator to estimate your expected dividend yield:

NervGen Pharma Financial Ratios

P/E ratio-7.17
PEG ratio-0.05
P/B ratio18.71
ROE-249.04%
Payout ratio0.00%
Current ratio1.66
Quick ratio1.66
Cash Ratio1.59

NervGen Pharma Dividend FAQ

Does NervGen Pharma stock pay dividends?
NervGen Pharma does not currently pay dividends to its shareholders.
Has NervGen Pharma ever paid a dividend?
No, NervGen Pharma has no a history of paying dividends to its shareholders. NervGen Pharma is not known for its dividend payments.
Why doesn't NervGen Pharma pay dividends?
There are several potential reasons why NervGen Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will NervGen Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While NervGen Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is NervGen Pharma a dividend aristocrat?
NervGen Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is NervGen Pharma a dividend king?
NervGen Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is NervGen Pharma a dividend stock?
No, NervGen Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy NervGen Pharma stocks?
To buy NervGen Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy NervGen Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.